| A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India U Kaur, B Ojha, BK Pathak, A Singh, KR Giri, A Singh, A Das, A Misra, ... EClinicalMedicine, 2021 | 75 | 2021 |
| Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer’s disease U Ganguly, U Kaur, SS Chakrabarti, P Sharma, BK Agrawal, L Saso, ... Oxidative Medicine and Cellular Longevity 2021, 1-19, 2021 | 63 | 2021 |
| Alpha-synuclein, proteotoxicity and Parkinson's disease: search for neuroprotective therapy U Ganguly, SS Chakrabarti, U Kaur, A Mukherjee, S Chakrabarti Current neuropharmacology 16 (7), 1086-1097, 2018 | 58 | 2018 |
| COVID-19 in India: are biological and environmental factors helping to stem the incidence and severity? SS Chakrabarti, U Kaur, A Banerjee, U Ganguly, T Banerjee, S Saha, ... Aging and Disease, 2020 | 57 | 2020 |
| Esketamine: a glimmer of hope in treatment-resistant depression U Kaur, BK Pathak, A Singh, SS Chakrabarti European archives of psychiatry and clinical neuroscience 271, 417-429, 2021 | 56 | 2021 |
| Targeting host cell proteases to prevent SARS-CoV-2 invasion U Kaur, SS Chakrabarti, B Ojha, BK Pathak, A Singh, L Saso, ... Current Drug Targets 22 (2), 192-201, 2021 | 44 | 2021 |
| New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies A Misra, SS Chakrabarti, IS Gambhir Indian Journal of Medical Research 148 (2), 135-144, 2018 | 42 | 2018 |
| Insomnia in the elderly—A hospital-based study from North India IS Gambhir, SS Chakrabarti, AR Sharma, DP Saran Journal of Clinical Gerontology and Geriatrics 5 (4), 117-121, 2014 | 41 | 2014 |
| Prevalence of dementia in India: National and state estimates from a nationwide study J Lee, E Meijer, KM Langa, M Ganguli, M Varghese, J Banerjee, ... Alzheimer's & Dementia 19 (7), 2898-2912, 2023 | 34 | 2023 |
| Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease U Ganguly, A Banerjee, SS Chakrabarti, U Kaur, O Sen, R Cappai, ... Biochemical Journal 477 (6), 1109-1122, 2020 | 32 | 2020 |
| Ceramide and sphingosine-1-phosphate in cell death pathways: relevance to the pathogenesis of Alzheimer's disease S Shubhra Chakrabarti, A Bir, J Poddar, M Sinha, A Ganguly, ... Current Alzheimer Research 13 (11), 1232-1248, 2016 | 31 | 2016 |
| Occurrence of COVID‐19 in priority groups receiving ChAdOx1 nCoV‐19 coronavirus vaccine (recombinant): a preliminary analysis from north India U Kaur, S Bala, B Ojha, S Jaiswal, S Kansal, SS Chakrabarti Journal of medical virology 94 (1), 407-412, 2022 | 30 | 2022 |
| Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2 U Kaur, K Acharya, R Mondal, A Singh, L Saso, S Chakrabarti, ... European journal of pharmacology 887, 173545, 2020 | 30 | 2020 |
| Antiepileptic drug therapy in the elderly: a clinical pharmacological review U Kaur, I Chauhan, IS Gambhir, SS Chakrabarti Acta Neurologica Belgica 119, 163-173, 2019 | 30 | 2019 |
| Zoledronate induced hypocalcemia and hypophosphatemia in osteoporosis: a cause of concern U Kaur, S Shubhra Chakrabarti, I Singh Gambhir Current drug safety 11 (3), 267-269, 2016 | 25 | 2016 |
| Of cross-immunity, herd immunity and country-specific plans: Experiences from COVID-19 in India SS Chakrabarti, U Kaur, A Singh, S Chakrabarti, M Krishnatreya, ... Aging and disease 11 (6), 1339, 2020 | 24 | 2020 |
| Rapidly progressive dementia with asymmetric rigidity following ChAdOx1 nCoV-19 vaccination SS Chakrabarti, A Tiwari, S Jaiswal, U Kaur, I Kumar, A Mittal, A Singh, ... Aging and disease 13 (3), 633, 2022 | 18 | 2022 |
| Acute cardiac events after ChAdOx1 nCoV-19 corona virus vaccine: report of three cases R Singh, SS Chakrabarti, IS Gambhir, A Verma, I Kumar, S Ghosh, ... American Journal of Therapeutics 29 (5), e579-e585, 2022 | 16* | 2022 |
| Multi-target directed ligands (MTDLs): promising coumarin hybrids for Alzheimer’s disease R Bhatia, SS Chakrabarti, U Kaur, G Parashar, A Banerjee, RK Rawal Current Alzheimer Research 18 (10), 802-830, 2021 | 15 | 2021 |
| Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis U Kaur, SS Chakrabarti, TK Patel Therapeutic Advances in Drug Safety 12, 20420986211011345, 2021 | 14 | 2021 |
Dr Upinder KaurAssistant Professor, Department of Pharmacology, Institute of Medical Sciences, Banaras HinduVerified email at bhu.ac.in
